The novel developed CYP2E1 inhibitor Q11, 1‐(4‐methyl‐5‐thialzolyl) ethenone, is effective on lung cancer in mice via regulation of the macrophage polarization in the tumor inflammatory microenvironment. Here, CYP2E1 is linked to lung carcinoma.